Abbott Laboratories GmbH
UkraineAll drugs from this manufacturer
-
The drug is used to treat exocrine pancreatic insufficiency in adults and children. This may be associated with cystic fibrosis, chronic pancreatitis, post-gastrectomy or post-pancreatectomy states, as well as Shwachman–Diamond syndrome.
Dosage form: capsules, hard with gastro-resistant granules
Active substance Dosage pancreatin 300 mg ATC: A09AA02
-
The drug is used to treat exocrine pancreatic insufficiency in adults and children. This may be associated with cystic fibrosis, chronic pancreatitis, post-operative states following stomach or pancreatic surgery, as well as Shwachman–Diamond syndrome.
Dosage form: capsules, hard with gastro-resistant granules
Active substance Dosage pancreatin 400 mg ATC: A09AA02
-
The drug is used to treat exocrine pancreatic insufficiency in adults and children. This may be associated with cystic fibrosis, chronic pancreatitis, post-gastrectomy or post-pancreatectomy status, as well as Shwachman–Diamond syndrome.
Dosage form: capsules, hard with gastro-resistant granules
Active substance Dosage pancreatin 150 mg ATC: A09AA02
-
The drug is used for pancreatic disorders accompanied by digestive problems, as well as to support pancreatic function in people with cystic fibrosis.
Dosage form: granules, gastro-resistant
Active substance Dosage pancreatin 60.12 mg ATC: A09AA02